Global Software as a Medical Device (SaMD) 麻豆原创 Research Report 2024

Publication ID:

PB506240021

Publication Date:

June 19, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function. The international medical device regulators forum (IMDRF), of which the US FDA is a member, describes SaMD as software that may work on general-purpose (non-medical) computing platforms; may be used in combination with other products including medical devices; and may interface with other medical devices or other general-purpose hardware and software that provide input to SaMD.
The global Software as a Medical Device (SaMD) market was valued at US$ 1312 million in 2023 and is anticipated to reach US$ 6108 million by 2030, witnessing a CAGR of 22.1% during the forecast period 2024-2030.
Global key players of Software as a Medical Device (SaMD) include MindMaze, Medtronic, iSchemaView, Viz.AI., Arterys, etc. The top five players hold a share about 18%.
This report aims to provide a comprehensive presentation of the global market for Software as a Medical Device (SaMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Software as a Medical Device (SaMD).
The Software as a Medical Device (SaMD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Software as a Medical Device (SaMD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Software as a Medical Device (SaMD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
MindMaze
Medtronic
iSchemaView
Viz.AI.
Arterys
Digital Diagnostics
Siemens Healthcare
Allscripts
Adherium
Segment by Type
Cloud-based
On Premise
Segment by Application
Screening and Diagnosis
Monitoring and Alerting
Chronic Disease Management
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Software as a Medical Device (SaMD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Software as a Medical Device (SaMD) 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud-based
1.2.3 On Premise
1.3 麻豆原创 by Application
1.3.1 Global Software as a Medical Device (SaMD) 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Screening and Diagnosis
1.3.3 Monitoring and Alerting
1.3.4 Chronic Disease Management
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Software as a Medical Device (SaMD) 麻豆原创 Perspective (2019-2030)
2.2 Global Software as a Medical Device (SaMD) Growth Trends by Region
2.2.1 Global Software as a Medical Device (SaMD) 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Software as a Medical Device (SaMD) Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Software as a Medical Device (SaMD) Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Software as a Medical Device (SaMD) 麻豆原创 Dynamics
2.3.1 Software as a Medical Device (SaMD) Industry Trends
2.3.2 Software as a Medical Device (SaMD) 麻豆原创 Drivers
2.3.3 Software as a Medical Device (SaMD) 麻豆原创 Challenges
2.3.4 Software as a Medical Device (SaMD) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Software as a Medical Device (SaMD) Players by Revenue
3.1.1 Global Top Software as a Medical Device (SaMD) Players by Revenue (2019-2024)
3.1.2 Global Software as a Medical Device (SaMD) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Software as a Medical Device (SaMD) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Software as a Medical Device (SaMD) Revenue
3.4 Global Software as a Medical Device (SaMD) 麻豆原创 Concentration Ratio
3.4.1 Global Software as a Medical Device (SaMD) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Software as a Medical Device (SaMD) Revenue in 2023
3.5 Global Key Players of Software as a Medical Device (SaMD) Head office and Area Served
3.6 Global Key Players of Software as a Medical Device (SaMD), Product and Application
3.7 Global Key Players of Software as a Medical Device (SaMD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Software as a Medical Device (SaMD) Breakdown Data by Type
4.1 Global Software as a Medical Device (SaMD) Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Software as a Medical Device (SaMD) Forecasted 麻豆原创 Size by Type (2025-2030)
5 Software as a Medical Device (SaMD) Breakdown Data by Application
5.1 Global Software as a Medical Device (SaMD) Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Software as a Medical Device (SaMD) Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Software as a Medical Device (SaMD) 麻豆原创 Size (2019-2030)
6.2 North America Software as a Medical Device (SaMD) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2019-2024)
6.4 North America Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Software as a Medical Device (SaMD) 麻豆原创 Size (2019-2030)
7.2 Europe Software as a Medical Device (SaMD) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2019-2024)
7.4 Europe Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Software as a Medical Device (SaMD) 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Software as a Medical Device (SaMD) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Software as a Medical Device (SaMD) 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Software as a Medical Device (SaMD) 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Software as a Medical Device (SaMD) 麻豆原创 Size (2019-2030)
9.2 Latin America Software as a Medical Device (SaMD) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Software as a Medical Device (SaMD) 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Software as a Medical Device (SaMD) 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Software as a Medical Device (SaMD) 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MindMaze
11.1.1 MindMaze Company Details
11.1.2 MindMaze Business Overview
11.1.3 MindMaze Software as a Medical Device (SaMD) Introduction
11.1.4 MindMaze Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.1.5 MindMaze Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Software as a Medical Device (SaMD) Introduction
11.2.4 Medtronic Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.2.5 Medtronic Recent Development
11.3 iSchemaView
11.3.1 iSchemaView Company Details
11.3.2 iSchemaView Business Overview
11.3.3 iSchemaView Software as a Medical Device (SaMD) Introduction
11.3.4 iSchemaView Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.3.5 iSchemaView Recent Development
11.4 Viz.AI.
11.4.1 Viz.AI. Company Details
11.4.2 Viz.AI. Business Overview
11.4.3 Viz.AI. Software as a Medical Device (SaMD) Introduction
11.4.4 Viz.AI. Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.4.5 Viz.AI. Recent Development
11.5 Arterys
11.5.1 Arterys Company Details
11.5.2 Arterys Business Overview
11.5.3 Arterys Software as a Medical Device (SaMD) Introduction
11.5.4 Arterys Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.5.5 Arterys Recent Development
11.6 Digital Diagnostics
11.6.1 Digital Diagnostics Company Details
11.6.2 Digital Diagnostics Business Overview
11.6.3 Digital Diagnostics Software as a Medical Device (SaMD) Introduction
11.6.4 Digital Diagnostics Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.6.5 Digital Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Software as a Medical Device (SaMD) Introduction
11.7.4 Siemens Healthcare Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.7.5 Siemens Healthcare Recent Development
11.8 Allscripts
11.8.1 Allscripts Company Details
11.8.2 Allscripts Business Overview
11.8.3 Allscripts Software as a Medical Device (SaMD) Introduction
11.8.4 Allscripts Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.8.5 Allscripts Recent Development
11.9 Adherium
11.9.1 Adherium Company Details
11.9.2 Adherium Business Overview
11.9.3 Adherium Software as a Medical Device (SaMD) Introduction
11.9.4 Adherium Revenue in Software as a Medical Device (SaMD) Business (2019-2024)
11.9.5 Adherium Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

MindMaze
Medtronic
iSchemaView
Viz.AI.
Arterys
Digital Diagnostics
Siemens Healthcare
Allscripts
Adherium

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.